We are live on ! Find out more
DXCM icon

DexCom
DXCM

795 hedge funds and large institutions have $51.1B invested in DexCom in 2021 Q3 according to their latest regulatory filings, with 117 funds opening new positions, 281 increasing their positions, 276 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

185% more first-time investments, than exits

New positions opened: 117 | Existing positions closed: 41

88% more funds holding in top 10

Funds holding in top 10: 8 → 15 (+7)

26% more capital invested

Capital invested by funds: $40.5B → $51.1B (+$10.5B)

18% more call options, than puts

Call options by funds: $1.09B | Put options by funds: $925M

10% more funds holding

Funds holding: 726 → 795 (+69)

2% more repeat investments, than reductions

Existing positions increased: 281 | Existing positions reduced: 276

5.17% less ownership

Funds ownership: 392.7% → 387.53% (-5.2%)

Holders
795
Holders Change
+69
Holders Change %
+9.5%
% of All Funds
13.92%
Holding in Top 10
15
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+87.5%
% of All Funds
0.26%
New
117
Increased
281
Reduced
276
Closed
41
Calls
$1.09B
Puts
$925M
Net Calls
+$170M
Net Calls Change
-$167M

Top Buyers

1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$199M
2
Sands Capital Management
Sands Capital Management
Virginia
+$145M
3
N
Nuveen
North Carolina
+$134M
4
1832 Asset Management
1832 Asset Management
Ontario, Canada
+$128M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$125M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$456M
2
JP Morgan Chase
JP Morgan Chase
New York
-$381M
3
LPC
Lone Pine Capital
Connecticut
-$215M
4
CS
Credit Suisse
Switzerland
-$129M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$128M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$5.66B +$47.1M +373,664 +0.9%
BlackRock
2
BlackRock
New York
$4.17B -$72.4M -574,268 -2%
Baillie Gifford & Co
3
Baillie Gifford & Co
United Kingdom
$2.93B +$67.2M +532,788 +3%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$2.49B +$125M +989,068 +6%
State Street
5
State Street
Massachusetts
$2.14B +$27.5M +217,856 +1%
Sands Capital Management
6
Sands Capital Management
Virginia
$1.82B +$145M +1,148,368 +9%
JP Morgan Chase
7
JP Morgan Chase
New York
$1.64B -$381M -3,020,880 -20%
Janus Henderson Group
8
Janus Henderson Group
United Kingdom
$1.43B -$128M -1,011,440 -9%
N
9
Nuveen
North Carolina
$1.15B +$134M +1,059,408 +14%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$979M +$23.4M +185,708 +3%
Artisan Partners
11
Artisan Partners
Wisconsin
$970M -$101M -798,480 -10%
Jennison Associates
12
Jennison Associates
New York
$844M -$27.2M -215,340 -3%
Capital Research Global Investors
13
Capital Research Global Investors
California
$836M +$49.5M +392,136 +7%
Capital World Investors
14
Capital World Investors
California
$824M -$99.9K -792 -0%
LPC
15
Lone Pine Capital
Connecticut
$788M -$215M -1,708,240 -23%
Brown Advisory
16
Brown Advisory
Maryland
$750M -$116M -920,416 -14%
Morgan Stanley
17
Morgan Stanley
New York
$681M -$456M -3,613,392 -42%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$666M -$7.13M -56,536 -1%
William Blair & Company
19
William Blair & Company
Illinois
$658M -$1.87M -14,820 -0.3%
UBS AM
20
UBS AM
Illinois
$607M -$20.3M -160,732 -3%
Northern Trust
21
Northern Trust
Illinois
$560M +$3.06M +24,252 +0.6%
CS
22
Credit Suisse
Switzerland
$549M -$129M -1,025,516 -20%
Wells Fargo
23
Wells Fargo
California
$546M -$16.8M -133,236 -3%
Wellington Management Group
24
Wellington Management Group
Massachusetts
$538M -$61.3M -486,280 -11%
Bank of America
25
Bank of America
North Carolina
$490M -$35.7M -283,392 -7%
1
2 3 4 5

DXCM Hedge Fund Activity: Q3 2021 in Review

795 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q3 2021, worth a combined $51.1B — up 26% from $40.5B a quarter earlier.

Buyers outnumbered sellers: 117 funds opened new DXCM positions and 41 closed out — a net gain of 76 holders — while 281 added to existing stakes and 276 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $199M. The largest seller was Morgan Stanley, cutting an estimated $456M.

  • 795 institutional investors held DexCom (DXCM) as of Q3 2021, up from 726 in Q2 2021.
  • Funds reported $51.1B of DexCom stock for Q3 2021, up 26% quarter-over-quarter.
  • 117 funds opened new DexCom positions in Q3 2021 and 41 closed out, a net change of +76 holders.
  • The largest DexCom buyer in Q3 2021 was Lord, Abbett & Co, an estimated $199M added.
  • The largest DexCom seller in Q3 2021 was Morgan Stanley, an estimated $456M sold.

Based on aggregated 13F filings for Q3 2021.